Chinese Mainland and Hong Kong IPO Markets Q1 2023 Review slide image

Chinese Mainland and Hong Kong IPO Markets Q1 2023 Review

2023 outlook: Hong Kong IPO market A healthy IPO pipeline The IPO pipeline remains healthy with over 90 applicants waiting for a right window to list in the bourse. Specialist technology companies The new regime is expected to further attract listings of emerging and innovative companies. Just as the launch of Chapter 18A led to a new biotech financing ecosystem in Hong Kong, we are confident that the new Specialist Technology Companies regime will help drive growth in talent and investments for specialist technologies in Hong Kong and beyond. In the long run, the development of a specialist technology financing ecosystem will diversify Hong Kong's capital markets and create a more appealing environment for both issuers and investors. International companies The expansion of Stock Connect to foreign companies helps to attract international companies to list in Hong Kong and gain access to Mainland investors. Irene Chu Partner Head of New Economy and Life Sciences KPMG China Note: All figures are as of 23 March 2023 Source: HKEX and KPMG analysis KPMG © 2023 KPMG, a Hong Kong (SAR) partnership, are member firms of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved Chinese Mainland and Hong Kong IPO markets | 19
View entire presentation